Related Experiment Video
Updated: Aug 16, 2026
04:32
13C6-Glucose Labeling Associated with LC-MS: Identification of Plant Primary Organs in Secondary Metabolite Synthesis
Published on: March 22, 2024
Insights into glucomoringin biosynthesis in moringa sprouts through integrated transcriptomic and metabolomic
Yi Liu1,2, Dejian Huang1,3, Shao Quan Liu1,3
1Department of Food Science and Technology, National University of Singapore, Singapore 117542, Singapore.
Food Chemistry. Molecular Sciences
|August 15, 2026
Summary
This study proposes a biosynthetic pathway for glucomoringin (GMG) in moringa sprouts, identifying key genes involved. These findings advance understanding of GMG production for potential anticancer applications.
Area of Science:
- Plant biochemistry
- Molecular biology
- Metabolomics
Background:
- Glucomoringin (GMG), a glucosinolate abundant in moringa, is a precursor to moringin (RBITC), an isothiocyanate with anticancer properties.
- Research on GMG biosynthesis in moringa sprouts is limited, necessitating further investigation.
Purpose of the Study:
- To propose a tyrosine-associated GMG biosynthetic pathway in moringa sprouts.
- To identify candidate genes involved in GMG biosynthesis and its conversion to RBITC.
Main Methods:
- Transcript annotation
- Metabolite prediction
- Bioinformatic analysis of candidate genes
Main Results:
- A putative tyrosine-associated GMG biosynthetic pathway was proposed.
- Candidate genes including *CYP79A1*, *CYP83B1*, *SUR1*, *UGT74B1*, and *SOT16* were identified for GMG biosynthesis.
- Genes *TGG4* and *TGG5* were tentatively identified as potentially involved in GMG to RBITC bioconversion.
Conclusions:
- The study provides valuable insights into the biosynthesis of GMG in moringa sprouts.
- Identified genes may serve as targets for enhancing GMG production for therapeutic applications.
